Factor V Leiden and Sickle Cell Disease

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Thrombosis and Haemostasis

• Publication date

  1996-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-0038-1650381PMID 8725738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism

  1995cited by this paper
• Coagulation Factor V Leiden Mutation May Have a Racial Background

  1995cited by this paper
• APC-Resistance and Mnl I Genotype (Gin 506) of Coagulation Factor V Are Rare in Japanese Population

  1995cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion.

  1991cited by this paper

• Factor V Leiden and prothrombin G20210A mutations and risk of vaso-occlusive complications in sickle cell disease: A meta-analysis through the lens of nephrology

  2019cites this paper
• The 20210A Allele of Prothrombin Is not Found among Sickle Cell Disease Patients from West Africa

  1998cites this paper
• Epidemiology of Factor V Leiden: Clinical Implications

  1998cites this paper
• Polymorphism in exon 10 of the human coagulation factor V gene in a population at risk for sickle cell disease

  1997cites this paper
• The Population Genetics of Factor V Leiden (Arg506Gln)

  1996cites this paper